ArticleIn vivo (Athens, Greece)

Durable Stable Disease by Atezolizumab/Bevacizumab Can Provide Long-term Survival of Patients With Hepatocellular Carcinoma Lung Metastases.

Toshihiko Motohara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.